| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . 640 . 650 . 660 . 670 . 680 . 690 . 700 . 710 . 720 . 730 . 740 . 750 . 760 . 770 . 780 . 790 . 800 . |
| # |
Score |
Template |
Links and tools | %id | First |
LLMTWWPSQETQRQYVNYMNAQLGINKTYDDTSNQLQLNIAAATIQAKIEAKITTLKNTDWLRQTISAFVKTQSAWNSDSEKPFDDHLQNGAVLYDNEGKLTPYANSNYRILNRTPTNQTGKKDPRYTADNTIGGYEFLLANDVDNSNPVVQAEQLNWLHFLMNFGNIYANDPDANFDSIRVDAVDNVDADLLQIAGDYLKAAKGIHKNDKAANDHLSILEAWSDNDTPYLHDDGDNMINMDNKLRLSLLFSLAKPLNQRSGMNPLITNSLVNRTDDNAETAAVPSYSFIRAHDSEVQDLIRDIIKAEINPNVVGYSFTMEEIKKAFEIYNKDLLATEKKYTHYNTALSYALLLTNKSSVPRVYYGDMFTDDGQYMAHKTINYEAIETLLKARIKYVSGGQAMRNQQVGNSEIITSVRYGKGALKATDTGDRTTRTSGVAVIEGNNPSLRLKASDRVVVNMGAAHKNQAYRPLLLTTDNGIKAYHSDQEAAGLVRYTNDRGELIFTAADIKGYANPQVSGYLGVWVPVGAAADQDVRVAASTAPSTDGKSVHQNAALDSRVMFEGFSNFQAFATKKEEYTNVVIAKNVDKFAEWGVTDFEMAPQYVSSTDGSFLDSVIQNGYAFTDRYDLGISKPNKYGTADDLVKAIKALHSKGIKVMADWVPDQMYAFPEKEVVTATRVDKFGKPVEGSQIKSVLYVADSKSSGKDQQAKYGGAFLEELQAKYPELFARKQISTGVPMDPSVKIKQWSAKYFNGTNILGRGAGYVLKDQATNTYFNISDNKEINFLPKTLLNQDSQVGFSYDGK | Last |
| 1 | -215.000 | PF02324.16; GTFB_STRMU/269-1074; Glycosyl hydrolase family 70 |
ali |
100 | 1 | LLMTWWPSQETQRQYVNYMNAQLGINKTYDDTSNQLQLNIAAATIQAKIEAKITTLKNTDWLRQTISAFVKTQSAWNSDSEKPFDDHLQNGAVLYDNEGKLTPYANSNYRILNRTPTNQTGKKDPRYTADNTIGGYEFLLANDVDNSNPVVQAEQLNWLHFLMNFGNIYANDPDANFDSIRVDAVDNVDADLLQIAGDYLKAAKGIHKNDKAANDHLSILEAWSDNDTPYLHDDGDNMINMDNKLRLSLLFSLAKPLNQRSGMNPLITNSLVNRTDDNAETAAVPSYSFIRAHDSEVQDLIRDIIKAEINPNVVGYSFTMEEIKKAFEIYNKDLLATEKKYTHYNTALSYALLLTNKSSVPRVYYGDMFTDDGQYMAHKTINYEAIETLLKARIKYVSGGQAMRNQQVGNSEIITSVRYGKGALKATDTGDRTTRTSGVAVIEGNNPSLRLKASDRVVVNMGAAHKNQAYRPLLLTTDNGIKAYHSDQEAAGLVRYTNDRGELIFTAADIKGYANPQVSGYLGVWVPVGAAADQDVRVAASTAPSTDGKSVHQNAALDSRVMFEGFSNFQAFATKKEEYTNVVIAKNVDKFAEWGVTDFEMAPQYVSSTDGSFLDSVIQNGYAFTDRYDLGISKPNKYGTADDLVKAIKALHSKGIKVMADWVPDQMYAFPEKEVVTATRVDKFGKPVEGSQIKSVLYVADSKSSGKDQQAKYGGAFLEELQAKYPELFARKQISTGVPMDPSVKIKQWSAKYFNGTNILGRGAGYVLKDQATNTYFNISDNKEINFLPKTLLNQDSQVGFSYDGK |
806 |
| 2 | -26.400 | PF00128.24; MALT_AEDAE/44-406; Alpha amylase, catalytic domain |
ali follow.. |
10 | 1 | ..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GDLDGVTEKLKYLKDIGMDGVWLSPIFSSP--------MADFGYDISNFREIQT----EYGDLDAFQRLSDKCKQLGLHLILDFVPNHTSDQHEYFKKSVQKDETYKDFYVWHPGVHSNWISVFRGSSWEWNEERQEFYLHQFLKEQPDLNYRNPAVVEEMKNV---LRYWLDRGVSGFRIDAVPYLFESDIIDGRY............................... |
191 |
| 3 | -17.100 | PF14872.6; D5A215_ARTPN/18-828; Hypothetical glycoside hydrolase 5 |
ali follow.. |
10 | 1 | ...................................................................................................................................................................................................................................................................................................................................................................................................NLLNWAATVEHSKASYFEKAQILAQKLGAHWLGDGLWTPKLTSQVMRRLEIFLEVLIPIDEIDLRADQQVVMQPGSREVGSFYWLRYIDQAEKLQAIRD---------LAYSLPYGVFGPAELYDIETLQAQRPDLEYFSRRGTSRHPTIDLHDDDLSPLPNPKLIPRVRAPKNILQLH------GTATAAGTFEGLTSLPLEENYIGYGAVQLLPTEDILEINLSKPDTQDWGYDVPILG--TNPAIMGSRRPDEVVDFIATLHTGPIQVIYDIVYGHA--------------------------------------DNQSELLLNRQFLKGQNMYGQDLNHQLPTVRAILLE---MQRRKMNTGVDGIRIDGGQ........................................... |
392 |
| 4 | -15.900 | PF14701.6; C8VTT8_EMENI/134-575; Glycogen debranching enzyme, glucanotransferase domain |
ali follow.. |
14 | 5 | ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LNALSIFSVNSKFM-------GKYPEDWNQYLNSISRRKYNMVHFTPLMKR--------GASNSPYSIFDQLQFDDIAFP--NGENDVQKLIKDMEEKSLLSLADVVWNHTANNSKW..................................................................................................................................... |
105 |
| 5 | -7.290 | PF14228.6; F6GVU1_VITVI/618-1735; Cell morphogenesis central region |
ali follow.. |
9 | 165 | .KLDQW------LMYAMFACSCPFDSREASSLGAAKDLYHGSEAHIHAATMALGHSHLEGELASFIDEVSMETEGKPKWKSQKARREELRVHIA---------------NIYRTVSENIWP---------------------GMLGRKPIFRLHYLKFIEETTRQILTAPSENFQEIQPLRYALAS-----VLRSLAPEFVDSKSEKFDLRTRKRLFDLLLSWCDDTGSTWVQDGVSDYRREVERYKSSQHSRSKDSVDKLSFDKEVSEQVEA---------------------------------------------------------------------QWASMNAMASLLYGP-------------FDDNARKMSGRVISWINSLFNEPAPRAPFGYSPADPRTPSYSKYTGEGPRGAAGRDRHRGGHLRVSMALKNLLLTNLDL-FPACIDQCYYSDAAIADGYFSVLAEVYMRQLSLILYKVVDPNRQIRDDALQMLETLSVREWAEDGGEGSGSYRAAVVGNLPDSY-----QQFQYKLSCKLAKDHPELSQLLCEEIMQRQLDAVDIIAQH--QVLTCMAPWIENLNFWK---------LKDSGWSERLLKS------LYYV----TWRHGDQDEIEKLWSTIKPRNISPVLDFLIT............................................................................................................................................. |
705 |
| 6 | -6.900 | PF16134.5; E9CUD7_COCPS/133-865; THO complex subunit 2 N-terminus |
ali follow.. |
10 | 5 | RIKNW--SSTGKQQVVEVGKEACSNVDTITLASLFQEVIQSAFECRIPVKQIIGERSDSNDGDRTAPYLAFDSHSIFLDTLSILTDADSSRENLRPLAFATGISPSLMRLQLDTPLLQALGRDTFGRMGIRKQTNILYRQSNNL------LREESEGYSKLLTELFTTSNNEPPIGMDVGRLDVTLDVFAAVLVKQYRFCVKFLRASSWWPKEDNAPEGGIGLGLPKWALPGSPGWSTTDEEREEALRLNEHRDRLFWDRAKQVGIKAFFEIGRSLASDSDNHMLVSDIDVETRDETQKWIEQTGTLPPKGNRVAAQL----LGFKLRFYSSDARNATDVLP-DNLIYLAALLIKV--GFISLLYPHLWRPDEEMEVLKEEKMKEKAEREKAGRRGAGMMNALMTAGALADDTLTLPARSRGLETRSATPAKEQEQDKDKTAPQKTEEKQKVLLLKSLLAIGALPESLY---ILGRFPWLLDGYPELPEYIHRILHYCLHK---VYQSVQPLPSRSELRDRKKIVGSEQGAVSQGRVRLSDAAPQRVLRWALLDKQDNDGTDYRFYWDDWTDSIPVCQSIDDVFALCSSFLNLSGCRRLLVPALSLTKNNPGVVNEVFE--FPQHVRFSI-------YAARFETKDALKRLSKTNVRPMA.................................................................................................................................................. |
732 |
| 7 | -6.880 | PF14488.6; D4IPL3_9BACT/51-219; Domain of unknown function (DUF4434 topsan) |
ali follow.. |
7 | 2 | ..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RATFLDEVSWDIPHQNWGVKEW----DADFKAMKQMGINTVVL-------------IRAGLGSWIAAPFDCLLRTGKVKYPPVDLVEMFLALSDKYGMDFWFGTYDS............................................................................................................................................. |
91 |
| 8 | -6.820 | PF12905.7; Q6A7F3_CUTAK/478-751; Endo-alpha-N-acetylgalactosaminidase |
ali follow.. |
12 | 1 | .....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QDAAVATRDVTMKPTGSGDVANKVITHIPFN-----------IVSQATHPFLRTLDDVKRISLATDGLGQQA-------LLKGYQAEGHD-SAHPDYGGNVSHRAGGMKDLEKLTESGRQWNTDFGIHVNLVESYPEANHFGDNLVKPYQKA......................................................................................................................... |
133 |
| 9 | -6.750 | PF00311.17; CAPP_SYNY3/193-1034; Phosphoenolpyruvate carboxylase |
ali follow.. |
8 | 6 | LVITAHPTEIVRHTIRRKQRR-------------DRILRKLDQLQGSVTGRDWLNTWDAKTAIAQLTEEIRFWWRTDELHQFKPTVLDEVDYSLHYFDEVLFDAVPELSKRLGQAIKETFPHLRAPRANFCYFGSW---VGGDRD-GNPSVTPEVTWQTACYQRGLVLGKYLFSLGELVAILSPSLHW-CKVSQELLDSLERDRIQLPEIYEELSLRYRQEPYRMKLAYVTKRLENTLRRNNRLANPEIQRNLTETGLTCLELENLISSRHAEAIAEIAEYMGVLTTPYEEMAEEDKLAWLGVELQT-RRPLIPQEMPFSERTRETIETL--RTLRHLQMEFGVDICQTYVLLLAKEAGVP-LF---------ETVEDLKNAPGIMDSLFSLAGSYHSLKELQNQPPDYYQIPTTTALLNPGNLQEIMVGYSDSNSSNWEIHKAQKSLQAVAQSHRVILRLFHGRGGSVGR---GGGPAYKAILAQPAGTVDGRIKITEQGEVLASKYSLPELALYNLTAVIQASLLKSSFDFIEPWNRIMEELACTARRAYRSLIYEEPDFLDFF-------------------LTVTPIPEISELQISSRPARRKGGKADLSSLRA-----VFSWTQTRFLLPAWYGVGTALKSFVDQDPVKNMKLLRYFYFK............................................................................................................................................. |
703 |
| 10 | -6.450 | PF03979.14; A6VU43_MARMS/3-80; Sigma-70 factor, region 1.1 |
ali follow.. |
15 | 4 | ........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QSRLKELISKG----------------------KEQGYLTYA--EVNDHLPDDLSDPEQVEEIIAMINDMGITVSEV................................................................................................................................................. |
56 |